Journals
Books
Articles by keyword breast cancer
Computer Model Based on Three-Dimensional Resistor Matrix for Researching of Distribution of Electric Potential in Electroimpedance Mammography
A.A. Semchenkov, A.N. Kalinichenko
GENETIC BOTH ECOLOGICAL RISK FACTORS AND STABILITY TO THE BREAST CANCER
L.A. Piruzjan, K.S. Gjulazizova, И.С. Nikolaeva, A.S. Kabankin, G.P. Sukhinina, N.E. Pynko, A.D. Radkevich, A.R. Kuznetsova, L.A. Radkevich
Holographic Radar in Breast Cancer Imaging
L.N. Anishchenko, I.A. Vasiliev, A.A. Demendeev, S.I. Ivashov, V.V. Razevig
The Method of Electroimpedance Diagnosis of the Breast Cancer
A.A. Semchenkov
Comparative immunoenzymatic study of nuclear transcription factor NF-κB, its inhibitor IκBα, and upstream effector protein kinase Akt1 expression and activity in the tumors of breast cancer patients
N.E. Kushlinsky, E.S. Gershtein, A.M. Scherbakov, A.M. Platova, G.Yu. Tchemeris, E.V. Oshkina, A.A. Tuleuova, V.P. Letyagin
IGF System and Breast Cancer
O.I. Kostyleva, A.V. Maslyaev, O.M. Kuznetsova, A.A. Tuleuova, U.R. Mamedov, I.V. Tereshkina, T.T. Berezov
Antitumor Effect of the Somatostatin Analogue Cifetrelin in Vivo
Е.I. Mikhaevich, N.P. Yavorskaya, I.S. Golubeva, N.A. Oborotova, R.N. Alyautdin
Matrix Metalloproteinases (MMPs) and Their Tissue Inhibitors (TIMPs), Role in the Breast Cancer Development
T.T. Berezov, O.M. Kuznetsova, A.Yu. Nazarenko, Yu.V. Kruk, I.V. Tereshkina
The Apoptosis Induction in vitro Cultured MCF-7 Breast Cancer Cells by the Novel Somatostatin Analog Cifetrelin
M.A. Krasil-nikov, E.I. Mikhaevich
IGF and their Receptors in Breast Cancer
O.I. Kostyleva, E.S. Gershteyn, A.V. Maslyaev, U.R. Mamedov
Serum Vascular Endothelial Growth Factor Content in Localized Breast Cancer and its Prognostic Significance
L.K. Ovchinnikova, M.V. Gritskevich, A.A. Tuleuova, O.M. Kuznetsova, G.N. Shvetsova, I.K. Vorotnikov, T.T. Berezov
Apoptosis Gene Expressions in Breast Cancer
E.A. Kudinova, O.V. Burmenskaya, V.K. Bozhenko, E.F. Vaskevich, O.S. Nepsha, N.V. Melnikova, I.D. Trocenko, D.Yu. Trofimov, G.T. Sukhih
Clinical Prospects of the Study of NF-κB Signaling Pathway Components Expression and Activity iN tHE Tumors of Breast Cancer Patients
E.S. Gershtein, A.M. Scherbakov, A.A. Tuleuova, L.K. Ovchinnikova, N.E. Kushlinskii
C-terminale-telopeptide of type I collagen in urine of patients with breast cancer - prognostic factor of bone metastases
N.N. Semenov, N.V. Lyubimova, N.E. Kushlinskii, M.R. Lichinitcer
Clinic and morphological parallels of early breast cancer in the international cooperation
I.V. Kolyadina, I.V. Poddubnaya, C.J.H. van_de_Velde, P.J.K. Kuppen, G.J. Liefers, N.G. Dekker-Ensink, E. Bastiaannet, A. Sajet, E. de Kruijf, G.A. Frank, D.V. Komov, A.S. Ozhereliev, A.I. Karseladze, V.D. Ermilova, Y.V. Vishnevskaya, N.P. Makarenko, K.A. Teterin, S.M. Banov
Comparison of the microwave medical antennas
S.G. Vesnin, M.K. Sedankin
Soluble FAS Receptor and Breast Cancer Prognosis
L.K. Ovtchinnikova, U.R. Mamedov, S.G. Abbasova, O.M. Kuznetsova, Z.K. Karabekova, A.A. Tuleulova, I.K. Vorotnikov
Inculin-like Growth Factors in Breast Cancer Patients - Serum
A.V. Masliaev, O.I. Kostyleva, E.S. Gershtein, V.D. Ermilova, V.M. Gritskevich, S.M. Portnoy
Sensitivity of Breast Cancer Cells Cultured in Vitro to Hypoxia: the Role of Estrogen Receptors Machinery
L.B. Stefanova, A.M. Scherbakov, O.E. Andreeva, N.A. Bolotina, I.V. Tereshkina, M.A. Krasil-nikov
Application of wavelet transform in the method of microwave radiometry
T.V. Istomina, L.V Kuts, V.I. Petrov
Early diagnostic of breast cancer in population mammographic screening
L.E. Komarova, R.Sh. Khasanov, R.R. Gamirov, M.G. Kalinkina, K.T. Shakirov, B.K. Mazitov
The role of Snail signaling pathway in the development of resistance to hypoxia in breast cancer cells
A.M. Scherbakov, L.B. Stefanova, O.E. Andreeva, D.V. Sorokin, M.A. Krasilnikov
Clinical prospects of the key NF-B system components study in the tumors of breast cancer patients
A.M. Sherbakov, E.S. Gershtein, N.E. Kushlinskii
Inculin-like growth factors in breast cancer patients - serum
A.V. Maslyaev - Oncologist, Russian N.N. Blokhin Cancer Research Center RAMS (Moscow) O.I. Kostyleva - PH.D. (Med.), Senior Research Scientist, Clinical biochemistry laborator, Russian N.N. Blokhin Cancer Research Center RAMS (Moscow) E.S. Gershtein - Dr.Sc. (Biol.), Professor, Leading Research Scientist, Clinical biochemistry laborator, Russian N.N. Blokhin Cancer Research Center RAMS (Moscow). E-mail: esgershtein@gmail.com V.D. Ermilova - Ph.D. (Med.), Leading Research Scientist, Russian N.N. Blokhin Cancer Research Center RAMS (Moscow) I.V. Vysotskaya - Dr.Sc. (Med.), Professor, First Moscow State Medical University I.M. Sechenov V.M. Gritskevich - Applicant, Moscow State Medical and Dental University A.I.Evdokimova S.M. Portnoy - Dr.Sc. (Med.), Russian N.N. Blokhin Cancer Research Center RAMS (Moscow)
The molecular mechanisms of hormonal resistance of breast cancer: the role of NF-kappaB and Snail1 signaling pathways
A.M. Scherbakov - Ph.D., Senior Researcher, Federal State Budgetary Institution «The N.N. Blokhin Russian Cancer Research Center» of the Russian Academy of Medical Sciences, Moscow, Russian Federation
O.E. Andreeva - Junior Researcher, Federal State Budgetary Institution «The N.N. Blokhin Russian Cancer Research Center» of the Russian Academy of Medical Sciences, Moscow, Russian Federation
A.A. Sharapov - Laboratory Assistant, Federal State Budgetary Institution «The N.N. Blokhin Russian Cancer Research Center» of the Russian Academy of Medical Sciences, Moscow, Russian Federation
R.K. Tanoyan - Laboratory Assistant, Federal State Budgetary Institution «The N.N. Blokhin Russian Cancer Research Center» of the Russian Academy of Medical Sciences, Moscow, Russian Federation
Clinical significance of vegf and upa evaluation in breast cancer
O.I. Kostyleva - Ph.D. (Med.), Russian Cancer Research Center of N.N. Blokhin Russian Academy of Medical Sciences, Moscow, Russia
L.K. Ovchinnikova - Ph.D. (Med.), Russian Cancer Research Center of N.N. Blokhin Russian Academy of Medical Sciences, Moscow, Russia
V.D. Ermilova - Ph.D. (Med.), Russian Cancer Research Center of N.N. Blokhin Russian Academy of Medical Sciences, Moscow, Russia
U.R. Mamedov - Ph.D. (Med.), Russian Cancer Research Center of N.N. Blokhin Russian Academy of Medical Sciences, Moscow, Russia
I.V. Tereshkina - Ph.D. (Med.), Russian Cancer Research Center of N.N. Blokhin Russian Academy of Medical Sciences, Moscow, Russia
M.V. Gritskevich - Post-graduate Student, Russian Cancer Research Center of N.N. Blokhin Russian Academy of Medical Sciences, Moscow, Russia
O.V. Kuznetsova - Ph.D. (Med.), Russian Cancer Research Center of N.N. Blokhin Russian Academy of Medical Sciences, Moscow, Russia
I.K. Vorotnikov - Dr.Sc. (Med.), Professor, Russian Cancer Research Center of N.N. Blokhin Russian Academy of Medical Sciences, Moscow, Russia
Quantitative image analysis of bone scintigraphy for predicting the chemotherapy effectiveness
N.А. Nikolov - Ph.D. (Eng.), Associate Professor, Department of Physical and Biomedical Electronics, National Technical University of Ukraine «Kiev Polytechnic Institute», Kiev, Ukraine; Associate Professor, Department of Telecommunication Technologiesof, State University of Telecommunications, Kiev, Ukraine
A.L. Kaminskaya - Ph.D. (Eng.), Head of Department of Nuclear Medicine, Kiev City Clinical Hospital, Kiev, Ukraine
M.V. Satir - Radiologist, Department Nuclear Medicine of «Institute Heart» of the Ministry of Health Ukraine, Kiev, Ukraine
O.Yu. Yaroshenko - Post-graduate Student, Department of Physical and Biomedical Electronics, National Technical University of Ukraine «Kiev Polytechnic Institute», Kiev, Ukraine; Engineer-Radiologist, Department Nuclear Medicine of «Institute Heart» of the Ministry of Health Ukraine, Kiev, Ukraine
I.V. Buhenskaya - Student, Department of Physical and Biomedical Electronics, National Technical University of Ukraine «Kiev Polytechnic Institute», Kiev, Ukraine
MicroRNA - new promising tumor biological markers and targets for chemothe-rapy. Part 2. Clinical studies of microRNA in oncologic diseases
A.N. Shirshova - Researcher, Laboratory of Pharmacogenomics, Institute of Chemical Biology and Fundamental Medicine Siberian Branchof the Russian Academy of Sciences (ICBFM SB RAS), Novosibirsk M.A. Smetanina - Ph.D.(Biol.), Researcher, Laboratory of Pharmacogenomics, Institute of Chemical Biology and Fundamental Medicine Siberian Branchof the Russian Academy of Sciences (ICBFM SB RAS), Novosibirsk V.N. Aushev - Ph.D.(Med.), Senior Researcher, Laboratory of Oncogenes Regulation, Carcinogenesis Institute, N.N.Blokhin Russian Cancer Research Center, Moscow M.L. Filipenko - Ph.D.(Biol.), Head of the laboratory of pharmacogenomics, Institute of Chemical Biology and Fundamental Medicine Siberian branchof the Russian Academy of Sciences, Novosibirsk N.E. Kushlinskii - Dr.Sc. (Med.), Professor, Head of the Clinical Biochemistry Laboratory, N.N. Blokhin Russian Cancer Research Center, Moscow
An experience of clinical application of NGS sequencing technology on MiSeq illumina platform for BRCA1 and BRCA2 mutations diagnostics
N.A. Ermolenko - Junior Research Scientist, Laboratory of Pharmacogenomics, Institute of Chemical Biology and Fun-damental Medicine Siberian Branch of the Russian Academy of Sciences (ICBFM SB RAS), Novosibirsk U.A. Boyarskykh - Ph.D. (Biol.), Junior Research Scientist, Laboratory of Pharmacogenomics, Institute of Chemical Biology and Fundamental Medicine Siberian Branch of the Russian Academy of Sciences (ICBFM SB RAS), Novosibirsk. E-mail: boyarskih.u@gmail.com A.A. Kechin - Post-graduate Student, Laboratory of Pharmacogenomics, Institute of Chemical Biology and Fundamental Medicine Siberian Branch of the Russian Academy of Sciences (ICBFM SB RAS), Novosibirsk State University. E-mail: a.a.kechin@gmail.com A.F. Lazarev - Dr.Sc. (Med.), Professor, Altai branch N.N. Blokhin Russian Cancer Research Center. E-mail: aoc@ab.ru V.D. Petrova - Ph.D. (Med.), Altai branch N.N. Blokhin Russian Cancer Research Center. E-mail: valent_04@mail.ru A.M. Mazitova  Student, Kazan Federal University. E-mail: sashamazitova@mail.ru N.E. Kushlinskii - Dr.Sc. (Med.), Professor, Head of the Clinical Biochemistry Laboratory, N.N. Blokhin Russian Cancer Research Center, Moscow. E-mail: biochimia@mtu-net.ru M.L. Philipenko - Ph.D. (Biol.), Head of the laboratory of pharmacogenomics, Institute of Chemical Biology and Funda-mental Medicine Siberian branch of the Russian Academy of Sciences, Novosibirsk. E-mail: mlfilipenko@gmail.co
PAK1 methylation in breast cancer cells
E.A. Avilova Aspirant, N.N. Blokhin Cancer Research Center, Moscow E-mail: k_avilova@mail.ru E.B. Kuznetsova Ph.D. (Biol.), Leading Research Scientist, I.M. Sechenov First Moscow State Medical University, Moscow M.V. Nemtsova Dr.Sc. (Biol.), Professor, Leading Research Scientist, Research Centre of Medical Genetics, Moscow E-mail: nemtsova_m_v@mail.ru A.M. Scherbakov Ph.D. (Biol.), Senior Research Scientist, N.N. Blokhin Cancer Research Center, Moscow E-mail: alex.scherbakov@gmail.com V.A. Shatskaya Ph.D. (Biol.), Senior Research Scientist, N.N. Blokhin Cancer Research Center, Moscow М.А. Krasil-nikov Dr.Sc. (Biol.), Professor, N.N. Blokhin Cancer Research Center, Moscow E-mail: krasilnikovm@main.crc.umos.ru
Breast cancer with basal cell differentiation: clinical course and 5-year out-comes
M.M. Fael - Post-graduate Student, Department of Tumors of the Skin, Soft Tissues, Breast Beds Thoracic Surgery, Russian Scientific Center of Roentgen Radiology MH RF, Moscow. E-mail: dutsun@list.ru O.P. Bliznyukov - Dr. Sc. (Med), Head of the Department of Pathology, Russian Scientific Center of Roentgen Radiology (RSCRR) MH RF N.V. Melnikova - Ph. D. (Med), Leading Researcher Scientist, Laboratory of Immunology, Stem Cell Technologies in On-cology, Russian Scientific Center of Roentgen Radiology (RSCRR) MH RF
Insuline-like growth factor system. Part 2: breast cancer. Igf-system in disease progression. Targeted therapy
Yu.S. Timofeev - Physician of Clinical Laboratory Diagnostics, Clinical Biochemistry laboratory, Russian Cancer Research Center of N.N. Blokhin (Moscow). E-mail: timofeev_lab@mail.ru U.R. Mamedov - Ph. D. (Med.), Senior Research Scientist, Russian Canter Research Center of N.N. Blokhin O.I. Kostyleva - Ph. D. (Med.), Senior Research Scientist, Russian Canter Research Center of N.N. Blokhin А.V. Маslyaev - Oncologist, Russian Canter Research Center of N.N. Blokhin I.K. Vorotnikov - Dr. Sc. (Med.), Professor, Russian Canter Research Center of N.N. Blokhin E.S. Gershtein - Dr. Sc. (Biol.), Russian Canter Research Center of N.N. Blokhin
Basic and acidic fibroblasts growth factors and cancerogenesis. Part i. Mechanisms of action, angiogenic and apoptotic effects
O.I. Kostyleva - Ph.D. (Med.), Senior Research Scientist, Russian Cancer Research Center of N.N. Blokhin, Moscow. Е-mail: ok_olga68@mail.ru E.A. Ten - Post-graduate Student, Moscow State Medical and Dental University named A.I. Evdokimov N.E. Kushlinskii - Dr.Sc. (Med.), Professor, Corresponding Member RAS, Russian Cancer Research Center of N.N. Blokhin, Moscow
Bioimpedance method for postmastectomy lymphedema diagnostics

A.Z. Galiamov – Student, Department “Medical and Technical Information Technologies”, 

Bauman Moscow State Technical University

E-mail: airat.gl@gmail.com

A.A. Zakirova – Resident, Clinic of Oncology, Plastic and Reconstructive Surgery and Radiology,  I.M. Sechenov First Moscow State Medical University

E-mail: albinazakirovasno@gmail.com

I.A. Kudashov – Ph.D. (Eng.), Associate Professor, Department “Medical and Technical Information  Technologies”, Bauman Moscow State Technical University

E-mail: kudashov@bmstu.ru

S.I. Shchukin – Dr. Sc. (Eng.), Professor, Head of Department “Medical and Technical Information Technologies”,  Bauman Moscow State Technical University

E-mail: schookin@mx.bmstu.ru

I.V. Reshetov – Academician of RAS, Dr. Sc. (Med.), Professor, Head of Oncology Center, Clinic of Oncology, Plastic and Reconstructive Surgery and Radiology, I.M. Sechenov First Moscow State Medical University

E-mail: reshetoviv@mail.ru

A.V. Shcherbachev – Post-graduate Student, Department “Medical and Technical Information Technologies”,  Bauman Moscow State Technical University

E-mail: sa0211825@gmail.com

METABOLISM OF HOMOCYSTEIN AND CYSTEIN ROLE IN BREAST CANCER

N.E. Kushlinskii – Dr.Sc. (Med.), Professor, Member-Correspondent of Russian Academy of Sciences, 

N.N. Blokhin National Medical Cancer Research Center (Moscow)

E.I. Alekseeva – Post-Graduate Student, N.N. Blokhin National Medical Cancer Research Center (Moscow)

A.V. Ivanov – Ph.D. (Biol.), Institute of General Pathology and Pathophysiology (Moscow)

E.A. Avilova – Ph.D. (Med.), N.N. Blokhin National Medical Cancer Research Center (Moscow)

E.S. Gershtein Dr.Sc. (Biol.), Professor, N.N. Blokhin National Medical Cancer Research Center (Moscow) A.A. Kubatiev – Dr.Sc. (Med.), Professor, Academician of Russian Academy of Sciences,  Institute of General Pathology and Pathophysiology (Moscow)

Biotechnical system for automated HER2-status determination in breast cancer via fluorescent in situ hybridization (FISH)

D.S. Makhov1, G.S. Razmakhaev2, E.N. Slavnova3, A.V. Samorodov4

1,4 Bauman Moscow State Technical University (Moscow, Russia)

2,3 Oncocytology department, P.A. Hertzen Moscow Oncology Research Institute (Moscow, Russia)

Evaluation of requirements for the sample size in the tasks of cytological diagnosis of breast cancer

A.V. Samorodov1

1 Bauman Moscow State Technical University (Moscow, Russia)

Modeling of the female breast thermal properties

V.Yu. Gorelova1, L.V. Zhorina2, F.V. Manucharyan3, A.I. Plokhikh4, A.A.R. Flores5

1–5 Bauman Moscow State Technical University (Moscow, Russia)
 

Mathematical modeling of heat exchange processes in a biological object when creating microwave radiothermographs

V.Y. Leushin 1, M.K. Sedankin2, E.A. Konyukhova3, N.O. Sapozhnikov4, K.A. Garmazhanova5, S.V. Chizhikov6, V.S. Sinavchian7

1,2,6,7 Bauman Moscow State Technical University (Moscow, Russia)
3–5 Russian Technological University (RTU MIREA) (Moscow, Russia)
 

Method for detecting perineural and intraneural invasion in breast cancer as a prognostic factor of tumor progression

M.V. Mnikhovich1, L.M. Erofeeva2, T.V. Bezuglova3, I.A. Shiripenko4, M.V. Lozina5, B.V. Malygin6, N.E. Kushlinskii7

1–5 Avtsyn Research Institute of Human Morphology of FSBSI «Petrovsky National Research Centre of Surgery» (Moscow, Russia)

4–6 Pirogov Russian National Research Medical University (Moscow, Russia)

7 N.N. Blokhin National Medical Research Center of Oncology
of the Ministry of Healthcare of the Russian Federation (Moscow, Russia)

1 mnichmaxim@yandex.ru, 7 biochimia@yandex.ru

Clinical significance of methylation of lncRNA genes MEG3, SEMA3B-AS1 in tumors of patients with luminal breast cancer

A.A. Osipova1, D.A. Ryabchikov2, S.V. Chulkova3, A.M. Burdennyy4, V.I. Loginov5, N.E. Kushlinskii6

1,6 Russian University of Medicine (Moscow, Russia)

2,3,6 N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia (Moscow, Russia)

3 I.I. Pirogov Russian National Research Medical University of the Russian Ministry of Health (Moscow, Russia)

4,5 Research Institute of General Pathology and Pathophysiology (Moscow, Russia)

5 Research Centre for Medical Genetics, (Moscow, Russia)

1 osipova_ronc@mail.ru